1-hexanol has been researched along with oxadiazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonini, G; Bullo, A; Caccuri, AM; De Maria, F; Federici, G; Filomeni, G; Ricci, G; Stella, L; Turella, P | 1 |
| Caccuri, AM; Cianfriglia, M; Ciriolo, MR; Dupuis, ML; Federici, G; Filomeni, G; Forini, O; Pezzola, S; Turella, P | 1 |
| Chen, D; Dong, SC; Feng, JF; Hu, TM; Liu, SW; Ma, R; Sha, HH; Wang, Z; Wu, JZ; Wu, Y; Zhang, JY | 1 |
1 review(s) available for 1-hexanol and oxadiazoles
| Article | Year |
|---|---|
6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound.
Topics: Antineoplastic Agents; Apoptosis; Azoles; Drug Resistance, Neoplasm; Glutathione S-Transferase pi; Hexanols; Humans; Neoplasms; Nitrobenzenes; Oxadiazoles | 2018 |
2 other study(ies) available for 1-hexanol and oxadiazoles
| Article | Year |
|---|---|
7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Multiple; Enzyme Inhibitors; Glutathione Transferase; Hexanols; Humans; K562 Cells; Kinetics; Microscopy, Fluorescence; Models, Chemical; Models, Molecular; Oxadiazoles; Peptides; Piperazines; Protein Binding; Protein Conformation; Spectrometry, Fluorescence; Spectrophotometry; Sulfhydryl Compounds; Temperature; Time Factors | 2005 |
6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Glutathione; Glutathione Transferase; Hexanols; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Necrosis; Oxadiazoles; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-jun; Substrate Specificity | 2008 |